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Human&glycoprotein (&gpI) cDNA was isolated from a liver cDNA library and sequenced. The cDNA encoded 2.19-residue hydrophobic signal 
peptide followed by the mature&p1 of 326 amino acid residues. In liver and in the hepatoma cell line HepG2 there are two mRNA species of 
about 1.4 and 4.3 kb, respectively, hybridizing specifically with the fllgpI cDNA. Upon isoelectric &using, recombinant &pI obtained from 
expression of&gpI cDNA in baby hamster kidney ceils showed the same pattern of bands asp,gpI isolated from plasma, and at least 5 polypeptides 
were visible. 
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1. INTRODUCTION 
&glycoprotein &gpI) or apolipoprotein H is a 
single chain perchloric acid-soluble plasma protein of 
about 55 000 A4, [1,2]. /$gpI interacts strongly with 
anionic surfaces such as DNA, heparin, or vesicles of 
negatively charged phospholipids or activated platelets, 
and is thereby capable of inhibiting the prothrombinase 
activity of activated platelets [3] as well as the activation 
of the intrinsic pathway of Mood coagulation [4]. The 
latter function is shared with the homologous b-subunit 
of blood coagulation factor XIII [5]. A large part (-35%) 
of p2gpI in plasma is found in association with lipo- 
protein fractions (LDL, VLDL, HDL) and chylo- 
microns [6]. Recently, /?,gpI in complex with negatively 
charged phospholipids was found to be the major anti- 
gen recognized by anticardiolipin autoantibodies [7]. 
The complete amino acid sequence of &gpI, the assign- 
ments of positions of N-glycosylation as well as partial 
localization of disulfide bridges have been published [2]. 
* The nucleotide sequence data reported will appear in the EMBL, 
GenBank and DDBJ Nucleotide Sequence Databases under the acces- 
sion number X53595. 
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/3,gpI is composed of 5 short consensus repeats (SCRs), 
a common structural motif found in a number of com- 
plement and non-complement proteins [8,9]. Due to mi- 
croheterogeneity in sialic acid content and also to dif- 
ferences in asialo-b2gpI, several band!:, are observed on 
isoelectric focusing [ 10,111. 
In this work we present the cDNA aitd derived amino 
acid sequences of human /?,gpI. Human /3,gpI cDNA 
was expressed in the baby Syrian hamster kidney fibro- 
blast cell line (BHIC) and the expression product was 
characterized. 
2. EXPERIMENTAL 
2. I. cDNA cloning and sequencing 
cDNA libraries were prepared as previously described from human 
liver and HepG2 (grown in the presence of poly-lysine) RNA [ 121. Two 
mixed-sequence deoxyribonucleotide probes corresponding to amino 
acid residues 4-9 and 19-24 (underlined in Fig. 1) were synthcsizcd. 
cDNA library screening, colony purification, cDNA sequencing and 
compilation of data were performed as described earlier [13]. The 
cDNA and derived amino acid sequences were compared to those in 
the GenEMBL (release 26) and the MIPSX (release 28) databases, 
respectively [14]. Northern blot analyses were performed as in [15]. 
2.2. Consfruciion of a BlspI expression vector 
BarnHI sites were introduced at the 3’ and 5’ ends of the cDNA. By 
site-specific mutagenesis [16] a BajnHI site was introduced at position 
1139 in the 3’ non-translated region of thefi,gpI cDNA employing the 
deoxyribonucleotide:S’(TlTAATTCAATTAGGA~ATGGATG- 
AACAAGAAAC)3’. An additional BarnHI site was introduced by 
ligation of the adaptor (5’(GGATCCACCATGATATCTCCAGTG- 
CTCATATTGTTC)3’ to the ,%I site located 27 bp 3’ to the transla- 
tion initiation site. The modified &gpI cDNA was introduced at a 
BumHI site of the mammalian expression vector Zem219b [17] to 
generate plasmid ~1099. 
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Fig. I. The cDNA and derived amino acid sequence of human /3:gpi. The SCRs are indicated above the amino acid sequence. The segments used 
as probes are underlined and the poly-A signal is in bold. Three amino acid differences [2] are encircled. l . N-bound carbohydrate. 
2.3. Erprcssion of r~cotnbitrunr /$gpI in tttanttttuliutt cdls 
Cells were grown in DMEM supplemented with 10% FCS. The 
expression vector ~1099 was transf’ected into subconfluent BHK cells 
by the calcium phosphate method. trypsinized after 48 h and diluted 
into medium containing 400 nM methotrcxate. After IO-12 days indi- 
vidual colonies are cloned out and expanded separately. 
A rabbit anti-human &pI antibody (titre: I mg/ml) was used for 
immunoblotting [ 181. Aliquots were drawn from the isolated media 
and spotted onto a nitrocellulose membrane which was subsequently 
incubated with buffers containing (i) 2% (w/v) bovine serum albumin 
(1 h): (ii) rabbit anti-human@,gpl antibody. diluted I:500 (overnight): 
(iii) pcroxidase conjugated swine antirabbit-IgC. diluted I: IO00 (I h): 
and (iv) I .4-phenylenediamine. 
Ouantificalion of recombinant /&gpl (r&gpl) was performed by 
a b 
18 S 
Fig. 2. Northern blot analysis of&gpl RNA. (a) human liver RNA: 
(b) tlepG2 cell (poly-lysinc added to the medium) RNA. 
184 
electroimmunoassay in agarose gels containing 0.2% (w/v) deoxycho- 
late [I91 and amplification of the immunoprecipitates by reaction with 
a secondary peroxidasc-labeled antibody [20]. Prior to quantification, 
the media were concentrated 40-fold on a Minicon IS spinal cord fluid 
concentrator. It was assumed that proportional amounts of calf albu- 
min (from the culture media) and r&gpl adhered unspecifically to the 
Minicon membrane. A serum standard containing I80 mg/l ofj31gpI 
was used as reference [ 191. 
Recombinant &gpI grown in serum-free media was partially puri- 
fied and concentrated by affinity chromatography on a heparin- 
Sepharose 4B column. 
Isoelectric focusing of @gpl desorbed from hcparin-Sepharosc 4B 
and concentrated on Minicon CS I5 was performed as previously 
described [IO]. Pharmalytes pH 5-8 and 3-10 were used. Following 
incutation with the rabbit anti-human p,gpl antibody. the focusing 
pattern was developed using a secondary peroxidasc-conjugated anti- 
body. 
3. RESULTS AND DISCUSSION 
A total of 160 000 recombinant clones from human 
liver and HepG2 cDNA libraries were initial!y sszreened 
with 2 synthetic probes and later with a Xltol-DruI 
cDNA fragment (position 61-1141; Fig. 1). Several pos- 
itive clones were isolated and an estimated hll-length 
/&gpl (liver) cDNA insert was randomly sequenced at 
least twice on each strand. The nucleotide sequence of 
1170 bp exclusive of the poly-A tail contains 33 bp of 
S-untranslated sequence preceding a translation initia- 
tion codon. The open reading frame encodes a 19 amino 
acid residue hydrophobic signal peptide and the 326 
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Fig. 3. Electroimmunoassay of rpgpl. Three ~1 samples of conditio- 
ned media from transfected cells (wells I-6). Tall and weak prccipita- 
tes represent bovine /Lgpl (control not shown), while low and dense 
precipitates represent r~gp1. Wells a-d contain human serum jIgpI 
standards (90. 180, 270, and 360 n@well, respectively). 
residues of mature /Y&gpI determined earlier [2]. Fol- 
lowing the stop codon (TAA) are 99 bp of 3’-untrans- 
lated sequence including the canonical poly-A signal 
sequence AATAAA positioned 26 bp upstream from 
the poly-A tail (Fig. 1). 
Recently rat BZgpI cDNA was sequenced [21] and the 
degree of identity with human BIgpI cDNA between 
positions 24 and 97, and 240 and 1068 (the coding re- 
gion; human numbering) was 83%. This high degree of 
identity indicates an evolutionarily rather well conser- 
ved sequence. The rat nucleotide sequence, however, 
does not contain the region between positions 97 and 
240 when compared to the human &gpI cDNA se- 
quence. This region does not represent a separate exon 
when compared to the human BZgpI gene structure (H. 
Okkels and T. Kristensen, unpublished results). It can- 
not be ruled out that there may be a major difference 
between ra! and human /&gpI similar to the differences 
seen between mouse and human C4b-binding proteins, 
a protein homologous to BagpI [15]. 
3.2. Norrltern blot anulysis 
Northern blots of total RNA from human liver, 
HepG2 and placenta revealed two RNA species hybri- 
dizing with the X/l&DraI cDNA fragment in liver and 
HepG2 cells (Fig. 2) while no p,gpI mRNA could be 
detected in placenta (results not shown). The 1.4 kb 
band represents the &gpI mRNA. Attempts to obtain 
cDNA clones representing the 4.3 kb RNA species were 
unsuccessful, even after close inspection of 125 positive 
clones by restriction analyses. It was therefore conclu- 
ded that the 4.3 kb RNA species may represent a non- 
polyadenylated precursor of /??gpI mRNA and there- 
fore is not represented in the oligo-(dT)-primed cDNA 
libraries. The intensity of the hybridization signals in 
the Northern blots of liver and HepG2 RNA were com- 
pared to that of human c+macroglobulin (results not 
shown) indicates a high level of /3,gpl mRNA. 
3.3. The human B,gpI amino acid sequence 
There is good agreement between the cDNA-derived 
amino acid sequence shown in Fig. 1 and the amino acid 
sequence published by Lozier et al. [2]. However, 3 dif- 
ferences are seen (encircled in Fig. 1): (1) Valt4’ [2] to 
Leu; (2) Cys’“’ [2] to Ser; and (3) Asn-(carbohydrate)‘6g 
[2] to Cys. The differences (1) and (2) may be the results 
of single base mutations while (3) involves changes in 
at least 2 base pairs. The five SCRs of/?2gpI are indica- 
ted in Fig. 1. The differences, Cys”’ [2] and Asn-(carbo- 
hydrate)16’ [2], do not conform to the SRC consensus 
[lo], and they were also found to be Ser and Cys, respec- 
tively, in the cDNA-derived amino acid sequences of rat 
BzgPI 1211. 
The fifth and most C-terminal of p2gpI shares a very 
low degree of identity with the other SCRs of f12gpI and 
with other known SCR sequences, and even though this 
sequence contains 6 instead of 4 half-cystine residues, 
it does not beiong to rhe novel classes of SCRs found 
among the selectins or in Pregnancy Associated Plasma 
Protein-A ([9] and T. Kristensen, 0. Sand and Sottrup- 
Jensen, unpublished results). In the SCRs Cys’ is bound 
to Cys3 and Cys’ to Cys4 [2,22]. However, this pattern 
may be violated in the fifth SCR of human &pI where 
PH 5 
PH 8 
A I3 
Fig. 4. lsoelcctric focusing at pH 5-8 of human serum &#I (lane A) 
and of rfi,gpl (lane B). /irrows mark the positions of bands, pH values 
arc shown at the right, 
185 
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Eozier et al. [2] have found Cys’ to be disulfide bound 
to Cys’ although C2 would be expected to be bound to 
Cys’, with residues 307-326 being arranged as a disul- 
fide bridged extension. 
3.4. Characterization of recombinant human pzgpI 
DotbIots of aliquots of media collected from transfec- 
ted BHK cells grown in the presence of 10% FCS sug- 
gested that low amounts of &gpI were being syn- 
thesized and secreted into the media. Fig. 3 shows that 
two immunoprecipitates were formed in elec- 
troimmunoassays of all samples originating from media 
drawn from cultured transfected cells, The weakest pre- 
cipitate forming the tallest rockets, however, was found 
to be due to pre_existing/3,gpI originating from the FCS 
added to the cell culture medium. The low rockets were 
due to rp2gpI secreted from the transfected cells. Quan- 
tification of &gpI showed that it was present at 0.2-2 
&ml. For further characterization of r/12gpI selected 
clones were grown in serum-free media, and rj2gpI was 
partially purified. Forty pg of r/12gpI constituting less 
than 1% of the total protein desorbed from the heparin- 
Sepharose 4B column was obtained. Isoelectric focusing 
of the preparation of rj12gpI revealed that rj12gpI 
showed the same type of microheterogeneity asnative 
human B2gpI (Fig. 4). The isoelectric points of the dif- 
ferent types of rj12gpI were, however, higher than the 
isoelectric points for the native human /3,gpI. The 
reason for this could be that rj2gpI is less sialylated than 
native human j12gpI. 
The perspectives of the results presented here are that 
expression of recombinant human &gpI cDNA gives a 
tool for studying the anticoagulant function of j$gpI in 
greater detail using cDNA expression mutants. 
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